PPD is the ideal consulting partner to assist with your biopharmaceutical product’s success from preclinical through post-approval.
PPD has vast experience and expertise in infectious diseases studies, combined with a large investigator network and microbiology labs.
PPD's Phase I Clinic conducts clinical studies to determine how new medicines act in the bodies of healthy volunteers.
View all of PPD's news releases.
An overview of anonymization strategy for clinical documents in response to EMA Policy 0043 and Policy 0070
Michael Gawkins, a director in technology, innovation and performance, advances ideas about the role of innovation in teams.
Philip Bartle, an associate director in clinical innovation, discusses the use of industry data standards, which can greatly drive efficiencies and reduce variations in data.
© 2019 Pharmaceutical Product Development, LLC. All rights reserved.